Strategic Research Centre call
Strategic Research Centres are virtual centres of research excellence and are intended to create multidisciplinary teams to address questions of strategic relevance to people with cystic fibrosis.
The purpose of the SRC programme?
The purpose of the SRC programme is to:
- Create clusters of internationally-competitive researchers
- Exploit opportunities in science where synergy amongst researchers provides advantages to solve complex questions
- Facilitate the development of new interdisciplinary research partnerships
- Where appropriate, widen awareness of cystic fibrosis research outside the traditional biomedical disciplines and so attract high quality PIs from new research disciplines to apply their skills and knowledge to cystic fibrosis research
- Provide an environment to recruit the brightest and best young researchers to cystic fibrosis research and foster their interest in cystic fibrosis such that they continue working in this field.
Extensive feedback from researchers and the CF community has revealed strong support for the SRC structure as a way of promoting international and multidisciplinary collaborative approaches to solve problems for people with cystic fibrosis.
The Trust aims to create a balanced portfolio of research programmes, with both early stage programmes and those addressing later stage clinical programmes. For the latter clinical studies, reference to the outcomes of the James Lind Alliance Priority Setting Partnership process is required.
- Expression of Interest (phase 1) deadline has now passed
- Announcement of results of phase 1: mid-July 2021
- Full proposal (stage 2) deadline: early September 2021
- Decision: February 2022
For general enquiries, please contact firstname.lastname@example.org.
Find out about our research priorities and how and when we are allocating funding to meet these requirements and have the greatest impact on cystic fibrosis research.
Find out about our mission to create a brighter future where everyone with cystic fibrosis can live long and healthy lives, unlimited by the condition.
Researchers are investigating a range of issues related to cystic fibrosis, from transplants to bacterial infections and gene therapy.